Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme
|Quality of Life Menopause Contraception||Drug: gestoden 60 mcg Drug: ethinylestradiol 15 mcg||Phase 4|
|Study Design:||Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
|Official Title:||Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme|
- Quality of life [ Time Frame: eleven months ]
- Quality of life in differents phases of menacme [ Time Frame: eleven months ]
|Study Start Date:||January 2008|
|Study Completion Date:||November 2008|
|Primary Completion Date:||November 2008 (Final data collection date for primary outcome measure)|
Experimental: gestoden and ethinylestradiol
Gestoden 60 mcg plus ethinylestradiol 15 mcg, once a day, administered in 24∕4 regimen, for three months.
The use of gestoden and ethinylestradiol can do an improvement of the quality of life before and after the use of the drug.Numerous large clinical trials have shown that this combination is as effective in preventing pregnancies as other oral contraceptives presently on the market. Irregular bleeding and spotting rates appear to be at least as good as older formulations. In general, the incidence of side effects associated with the progestin and estrogen components tends to be low, with very little impact on lipid and carbohydrate metabolism. . For this, the regimen can ameliorate the quality of life of the patients.
Drug: gestoden 60 mcg
gestoden 60 mcg, once a day, administered in 24/4 regimen.
Other Names:Drug: ethinylestradiol 15 mcg
ethinylestradiol 15 mcg, once a day, administered in 24/4 regimen
Please refer to this study by its ClinicalTrials.gov identifier: NCT01174524
|Hospital Geral de Fortaleza|
|Fortaleza, Ceara, Brazil, 60115290|
|Principal Investigator:||joao MM Silva, PhD Student||Hospital Geral de Fortaleza|